Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)
|ClinicalTrials.gov Identifier: NCT01218295|
Recruitment Status : Unknown
Verified October 2010 by Università degli Studi di Ferrara.
Recruitment status was: Recruiting
First Posted : October 11, 2010
Last Update Posted : October 11, 2010
Many studies suggest that inspiratory muscles training by means of normocapnic hyperpnea improves exercise tolerance in healthy subjects. No information is available about the use of this training in COPD patients even if other methods (such as threshold loading and resistive loading) have been shown to be effective in terms of Inspiratory Muscle Function, Health-Related Quality of Life and Exercise Tolerance.
This study is designed to evaluate the effects of normocapnic hyperventilation by means of Spirotiger®, an instrument training the respiratory muscles, avoiding hypocapnia (using the methodology of isocapnic hyperpnoea)in COPD patients.
|Condition or disease||Intervention/treatment|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Efficacy of Inspiratory Muscle Training by Means of Spirotiger® in COPD Patients.|
|Study Start Date :||May 2009|
|Estimated Primary Completion Date :||June 2011|
|Estimated Study Completion Date :||July 2011|
Experimental: Respiratory muscle training
Patients assigned to this arm train the respiratory muscles by means of normocapnic hyperpnea.
training session :10 minutes twice a day X 4 weeks
Other Name: Pulmonary rehabilitation
- Exercise Capacity [ Time Frame: 1 month ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01218295
|Contact: Annalisa Cogo, MDemail@example.com|
|Contact: Luca Pomidori, PhDfirstname.lastname@example.org|
|Pulmonary Respiratory Unit- University Hospital||Recruiting|
|Ferrara, Italy, 44100|
|Contact: Annalisa Cogo, MD +390532210420 email@example.com|
|Contact: Luca Pomidori, PhD +390532455888 firstname.lastname@example.org|
|Principal Investigator:||Annalisa Cogo, MD||Università di Ferrara|